Tapiero Jacques 4
4 · MCCORMICK & CO INC · Filed Feb 9, 2026
Research Summary
AI-generated summary of this filing
McCormick (MKC) Director Jacques Tapiero Exercises Options, Sells Shares
What Happened
- Director Jacques Tapiero exercised/converted derivatives to acquire 5,000 McCormick (MKC) shares on 2026-02-05 (recorded purchase value $249,800 at $49.96/share) and sold 5,000 shares the same day in an open-market sale for $67.09/share (proceeds $335,450). The filing also shows a derivative conversion/settlement line at $0 and a subsequent grant of 2,598 restricted stock units (RSUs) on 2026-02-06 (no cash paid). The same-day exercise and sale is effectively a cashless exercise followed by a sale (sale proceeds exceed the exercise cost).
Key Details
- Transaction dates and prices:
- 2026-02-05: Exercised/conversion (M) 5,000 shares @ $49.96 — cost $249,800 (Acquired).
- 2026-02-05: Open-market sale (S) 5,000 shares @ $67.09 — proceeds $335,450 (Disposed).
- 2026-02-05: Exercise/conversion (M) 5,000 shares @ $0.00 — listed as a derivative disposition (no cash value).
- 2026-02-06: Grant/award (A) 2,598 RSUs @ $0.00 — reported as an acquisition of a contingent right.
- Shares owned after transaction: Not specified in the information provided in this summary (see filing for total beneficial ownership).
- Footnotes of note:
- F1: Phantom stock = right to receive one voting share; payable in shares under the Non‑Qualified Retirement Savings Plan.
- F2: Option exercised; no purchase price required for that entry (explains the $0.00 exercise line).
- F3: Each RSU is a contingent right to one share.
- F4: The RSUs vest in full on 2027-02-15 and will be settled in McCormick shares.
- Filing timeliness: Transaction reported on Form 4 filed 2026-02-09 for transactions on 2026-02-05. That filing date appears timely (filed within the standard reporting window).
Context
- This was an exercise/conversion of derivative awards followed by an immediate open‑market sale of the same number of shares — a common cashless-exercise pattern where options/derivatives are converted and shares are sold to cover costs or take gains. The RSU grant is a separate award that vests in Feb 2027 and will convert into shares at vesting; it does not represent an immediate purchase or sale. As always, filings state transactions but do not explain the insider’s motives.
Insider Transaction Report
Form 4
Tapiero Jacques
Director
Transactions
- Exercise/Conversion
Common Stock - Voting
2026-02-05$49.96/sh+5,000$249,800→ 36,596.054 total - Sale
Common Stock - Voting
2026-02-05$67.09/sh−5,000$335,450→ 31,596.054 total - Exercise/Conversion
Options - Right to Buy
[F2]2026-02-05−5,000→ 0 totalExercise: $67.09From: 2017-03-30Exp: 2026-03-29→ Common Stock - Voting (5,000 underlying) - Award
Restricted Stock Units
[F3][F4]2026-02-06+2,598→ 2,598 total→ Common Stock - Voting (2,598 underlying)
Holdings
- 2,620
Common Stock - Non Voting
- 2,206.082(indirect: Non Qualified Retirement Savings Plan)
Phantom Stock
[F1]→ Common Stock - Voting (0 underlying)
Footnotes (4)
- [F1]Each share of phantom stock represents the right to receive one share of Common Stock - Voting. Shares of Phantom Stock are payable in shares of Common Stock - Voting in accordance with the terms of the Non-Qualified Retirement Savings Plan.
- [F2]Option exercised; no purchase price required.
- [F3]The Restricted Stock Unit represents a contingent right to receive one share of Common Stock.
- [F4]The Restricted Stock Units vest in full on 2/15/2027 and are settled in an equal number of shares of McCormick stock.
Signature
Jason E. Wynn, Attorney-in-fact|2026-02-09